These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16690522)

  • 21. [Current chemotherapeutic trends in the treatment of malignant lymphomas with special reference to Hodgkin's disease].
    Novi C
    Minerva Med; 1975 Feb; 66(8):391-8. PubMed ID: 1089921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
    Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
    J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irinotecan in relapsed or refractory non-Hodgkin's lymphoma.
    Sarris AH; Romaguera J; Hagemeister FB; Rodriguez MA; McLaughlin P; Pro B; Younes A; Mesina O; Cabanillas F; Medeiros LJ; Samuels B
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):53-6. PubMed ID: 11497233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Short-term result of non-Hodgkin's lymphoma treated by the COMP regimen].
    Tang WY; He GF; Din GX; Sun ZY
    Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):140-2. PubMed ID: 3652916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of GDP regimen (gemcitabine, dexamethasone, and cisplatin) on relapsed or refractory aggressive non-Hodgkin's Lymphoma: a report of 24 cases].
    Fan Y; Huang ZY; Luo LH; Yu HF
    Ai Zheng; 2008 Nov; 27(11):1222-5. PubMed ID: 19000458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
    Mandigers CM; Verdonck LF; Meijerink JP; Dekker AW; Schattenberg AV; Raemaekers JM
    Bone Marrow Transplant; 2003 Dec; 32(12):1159-63. PubMed ID: 14647270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preliminary observations on the results of treating malignant lymphoma with Lycurim].
    Polubiec A; Kolakowska-Polubiec K; Mariańska B; Perzanowska I
    Acta Haematol Pol; 1977; 8(3):213-9. PubMed ID: 200051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NATULAN IN MANAGEMENT OF LATE HODGKIN'S DISEASE, OTHER LYMPHORETICULAR NEOPLASMS, AND MALIGNANT MELANOMA.
    TODD ID
    Br Med J; 1965 Mar; 1(5435):628-31. PubMed ID: 14245179
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination of chemotherapy and antiviral therapy for Epstein-Barr virus-associated non-Hodgkin's lymphoma of high grade malignancy in cases of HIV infection.
    Brockmeyer NH; Pohl G; Mertins L
    Eur J Med Res; 1997 Mar; 2(3):133-5. PubMed ID: 9113504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fludarabine: a review of its use in non-Hodgkin's lymphoma.
    Anderson VR; Perry CM
    Drugs; 2007; 67(11):1633-55. PubMed ID: 17661532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
    Pouillart P; Hayat M; Schwarzenberg L; Amiel JL; Mathé G; Tubiana M
    Br J Cancer Suppl; 1975 Mar; 2():505-11. PubMed ID: 52369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
    Tessoulin B; Thomare P; Delande E; Moynard J; Gastinne T; Moreau A; Bossard C; Mahé B; Blin N; Dubruille V; Touzeau C; Boudreault JS; Perrin F; Lok A; Guillaume T; Garnier A; Peterlin P; Gallas P; Chevallier P; Moreau P; Le Gouill S
    Ann Hematol; 2017 Jun; 96(6):943-950. PubMed ID: 28374163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.
    Jabbour E; Peslin N; Arnaud P; Ferme C; Carde P; Vantelon JM; Bocaccio C; Bourhis JH; Koscielny S; Ribrag V
    Leuk Lymphoma; 2005 Jun; 46(6):861-7. PubMed ID: 16019530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E
    Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
    [No Abstract]   [Full Text] [Related]  

  • 36. Mitoxantrone alone or in combination chemotherapy (VeMP) as second-line treatment in relapsed or refractory poor-prognosis non-Hodgkin's lymphoma. A report of the Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG).
    Santini G; Contu A; Porcellini A; Chisesi T; Coser P; Congiu AM; Morandi S; Manna A; Schintu GM; Quaini R
    Haematologica; 1991; 76(6):485-90. PubMed ID: 1820985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906.
    Smith SM; Johnson JL; Niedzwiecki D; Eder JP; Canellos G; Cheson BD; Bartlett NL;
    Leuk Lymphoma; 2006 Aug; 47(8):1511-7. PubMed ID: 16966261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of the indolent non-Hodgkin's lymphomas.
    Portlock CS
    Semin Oncol; 1980 Sep; 7(3):292-301. PubMed ID: 6158100
    [No Abstract]   [Full Text] [Related]  

  • 39. New chemotherapeutic agents for the treatment of low-grade non-Hodgkin's lymphomas.
    Cheson BD
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):96-110. PubMed ID: 8105539
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.